Walgreens Boots Alliance, Inc.: Financial Data Forecasts Estimates and Expectations | WBA | US9314271084 | MarketScreener (2024)

Real-time Estimate Cboe BZX

Other stock markets

12:15:35 2024-05-30 pm EDT
5-day change 1st Jan Change
15.39 USD +3.36% Walgreens Boots Alliance, Inc.: Financial Data Forecasts Estimates and Expectations | WBA | US9314271084 | MarketScreener (1) -3.04% -40.77%
May. 29 Nvidia soon to join the Dow Jones? Walgreens Boots Alliance, Inc.: Financial Data Forecasts Estimates and Expectations | WBA | US9314271084 | MarketScreener (2)
May. 23 Health Care Limits Losses Amid Defensive Bias - Health Care Roundup DJ

Valuation

Fiscal Period: August 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 46,232 32,946 43,898 30,301 21,849 12,846 - -
Enterprise Value (EV) 1 62,045 48,668 51,685 39,503 30,172 20,019 19,623 18,789
P/E ratio 11.9x 73.1x 17.3x 7x -7.09x -1.78x 7.56x 6.38x
Yield 3.47% 4.92% 3.7% 5.45% - 9.49% 6.97% 8.51%
Capitalization / Revenue 0.34x 0.24x 0.33x 0.23x 0.16x 0.09x 0.09x 0.08x
EV / Revenue 0.45x 0.35x 0.39x 0.3x 0.22x 0.14x 0.13x 0.12x
EV / EBITDA 7.37x 6.82x 7.87x 6.3x 6.03x 4.08x 3.73x 3.08x
EV / FCF 15.9x 11.8x 12.4x 18.2x 214x 14.4x 8.89x 7.11x
FCF Yield 6.27% 8.45% 8.08% 5.48% 0.47% 6.94% 11.2% 14.1%
Price to Book 1.95x 1.59x 1.84x 1.03x 0.77x 0.87x 0.83x 0.73x
Nbr of stocks (in thousands) 903,143 866,534 864,987 864,257 863,261 862,713 - -
Reference price 2 51.19 38.02 50.75 35.06 25.31 14.89 14.89 14.89
Announcement Date 10/28/19 10/15/20 10/14/21 10/13/22 10/12/23 - - -

Income Statement Evolution (Annual data)

Fiscal Period: August 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 136,866 139,537 132,509 132,703 139,081 145,306 150,788 157,141
EBITDA 1 8,413 7,138 6,567 6,268 5,002 4,906 5,259 6,100
EBIT 1 6,942 5,211 5,117 5,133 3,871 3,051 3,512 3,947
Operating Margin 5.07% 3.73% 3.86% 3.87% 2.78% 2.1% 2.33% 2.51%
Earnings before Tax (EBT) 1 4,527 743 1,995 3,985 -5,419 -12,945 1,529 1,333
Net income 1 3,982 456 2,542 4,337 -3,080 -7,176 1,806 2,163
Net margin 2.91% 0.33% 1.92% 3.27% -2.21% -4.94% 1.2% 1.38%
EPS 2 4.310 0.5200 2.930 5.010 -3.570 -8.371 1.969 2.335
Free Cash Flow 1 3,892 4,111 4,176 2,165 141 1,389 2,207 2,643
FCF margin 2.84% 2.95% 3.15% 1.63% 0.1% 0.96% 1.46% 1.68%
FCF Conversion (EBITDA) 46.26% 57.59% 63.59% 34.54% 2.82% 28.31% 41.97% 43.32%
FCF Conversion (Net income) 97.74% 901.54% 164.28% 49.92% - - 122.22% 122.21%
Dividend per Share 2 1.778 1.870 1.880 1.912 - 1.414 1.038 1.267
Announcement Date 10/28/19 10/15/20 10/14/21 10/13/22 10/12/23 - - -

1USD in Million2USD

Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: August 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2 2025 Q3
Net sales 1 33,901 33,756 32,597 32,449 33,382 34,862 35,415 35,422 36,707 37,052 35,967 36,066 37,764 37,899 37,589
EBITDA 1 2,277 1,931 1,232 993 1,510 1,774 1,556 1,013 1,028 1,244 1,147 1,131 1,362 1,474 1,346
EBIT 1 1,777 1,657 955 744 1,014 1,215 959 683 687 900 740.6 726.2 836.8 1,037 943.3
Operating Margin 5.24% 4.91% 2.93% 2.29% 3.04% 3.49% 2.71% 1.93% 1.87% 2.43% 2.06% 2.01% 2.22% 2.74% 2.51%
Earnings before Tax (EBT) 1 3,814 947 -18 -758 -5,270 607 -382 -375 -358 -13,114 321.5 264.8 438.2 579.2 542.7
Net income 1 3,580 883 289 -415 -3,721 703 118 -180 -67 -5,908 233.3 236.2 361.3 507.9 457
Net margin 10.56% 2.62% 0.89% -1.28% -11.15% 2.02% 0.33% -0.51% -0.18% -15.95% 0.65% 0.66% 0.96% 1.34% 1.22%
EPS 2 4.130 1.020 0.3300 -0.4800 -4.310 0.8100 0.1400 -0.2100 -0.0800 -6.850 0.2333 0.2455 0.3820 0.5579 0.4961
Dividend per Share 2 0.4775 0.4775 0.4775 0.4800 0.4800 - 0.4800 - 0.2500 0.2500 0.2500 0.2500 0.2500 0.3638 0.2500
Announcement Date 1/6/22 3/31/22 6/30/22 10/13/22 1/5/23 3/28/23 6/27/23 10/12/23 1/4/24 3/28/24 - - - - -

1USD in Million2USD

Estimates

Balance Sheet Analysis

Fiscal Period: August 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 15,813 15,722 7,787 9,202 8,323 7,173 6,777 5,943
Net Cash position 1 - - - - - - - -
Leverage (Debt/EBITDA) 1.88x 2.203x 1.186x 1.468x 1.664x 1.462x 1.289x 0.9743x
Free Cash Flow 1 3,892 4,111 4,176 2,165 141 1,389 2,207 2,643
ROE (net income / shareholders' equity) 22.3% 18.9% 20.5% 16.4% 11.9% 13.7% 18.6% 19.2%
ROA (Net income/ Total Assets) 5.87% 0.59% 5.46% 5.06% 3.68% -9.79% 2.02% 2.6%
Assets 1 67,861 77,380 46,566 85,705 -83,627 73,278 89,445 83,174
Book Value Per Share 2 26.30 23.80 27.50 34.00 32.80 17.10 18.00 20.40
Cash Flow per Share 2 6.060 6.230 6.410 4.500 2.620 4.320 4.460 4.490
Capex 1 1,702 1,374 1,379 1,734 2,117 1,543 1,610 1,681
Capex / Sales 1.24% 0.98% 1.04% 1.31% 1.52% 1.06% 1.07% 1.07%
Announcement Date 10/28/19 10/15/20 10/14/21 10/13/22 10/12/23 - - -

1USD in Million2USD

Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for Walgreens Boots Alliance, Inc.

Trading Rating

Investor Rating

ESG Refinitiv

B-

More Ratings

Analysts' Consensus

Sell

Walgreens Boots Alliance, Inc.: Financial Data Forecasts Estimates and Expectations | WBA | US9314271084 | MarketScreener (3)

Buy

Mean consensus

HOLD

Number of Analysts

19

Last Close Price

14.89USD

Average target price

22.77USD

Spread / Average Target

+52.93%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Drug Retailers

1st Jan change Capi.

WALGREENS BOOTS ALLIANCE, INC.

-42.91% 12.85B

JD HEALTH INTERNATIONAL INC.

-31.07% 11.12B

ALIBABA HEALTH INFORMATION TECHNOLOGY LIMITED

-15.33% 7.31B

YIFENG PHARMACY CHAIN CO., LTD.

+14.51% 6.39B

-13.20% 5.68B

CORPORATIVO FRAGUA, S.A.B. DE C.V.

+73.90% 4.95B

NAHDI MEDICAL COMPANY

-3.36% 4.63B

CLICKS GROUP LIMITED

-6.07% 3.96B

DASHENLIN PHARMACEUTICAL GROUP CO., LTD.

-18.76% 3.18B

WELCIA HOLDINGS CO., LTD.

-13.46% 2.79B

Other Drug Retailers

  1. Stock Market
  2. Equities
  3. WBA Stock
  4. Financials Walgreens Boots Alliance, Inc.
Like the pros, access all the transcripts and spot the best opportunities before anyone else. Unlock them now!

Walgreens Boots Alliance, Inc.: Financial Data Forecasts Estimates and Expectations | WBA | US9314271084 | MarketScreener (14)

"); InvestingChannelQueue.push(function() { aICTags["oop"] = ic_page.defineOutOfPageTag("4Traders/quotepages","zppOOP"); aICTags["oop"].setKval({"adslot":"d_OOP_1"}); aICTags["oop"].render(); }); while (aAdsQueue.length) { (aAdsQueue.shift())(); } InvestingChannelQueue.push(function() { displayViewableAds('InvestingChannel'); $( window ).scroll(function() { displayViewableAds('InvestingChannel'); }); }); }gaEvent('adspv', 'InvestingChannel', 'US');googletag.cmd.push(function() { googletag.pubads().setTargeting('Edition', 'en_US');googletag.pubads().setTargeting('UserType', 'free');googletag.pubads().setTargeting('Content', 'equities');googletag.pubads().setTargeting('codezb', '19356230');googletag.enableServices();googletag.pubads().collapseEmptyDivs();try{googletag.pubads().getSlots().forEach(function(slot){if(slot.getSlotElementId().startsWith('zpp')){;}else{googletag.pubads().refresh([slot],{changeCorrelator: false});}})}catch(error){console.error(error)}});$(document).ready(function() { $( document).on('zbv_visible',function () {startAdsService();}); if (document[zbv_hidden]===false) { startAdsService(); } });
Walgreens Boots Alliance, Inc.: Financial Data Forecasts Estimates and Expectations | WBA | US9314271084 | MarketScreener (2024)

References

Top Articles
Latest Posts
Article information

Author: Kareem Mueller DO

Last Updated:

Views: 6031

Rating: 4.6 / 5 (66 voted)

Reviews: 81% of readers found this page helpful

Author information

Name: Kareem Mueller DO

Birthday: 1997-01-04

Address: Apt. 156 12935 Runolfsdottir Mission, Greenfort, MN 74384-6749

Phone: +16704982844747

Job: Corporate Administration Planner

Hobby: Mountain biking, Jewelry making, Stone skipping, Lacemaking, Knife making, Scrapbooking, Letterboxing

Introduction: My name is Kareem Mueller DO, I am a vivacious, super, thoughtful, excited, handsome, beautiful, combative person who loves writing and wants to share my knowledge and understanding with you.